SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-22-008503
Filing Date
2022-08-08
Accepted
2022-08-08 17:06:33
Documents
78
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tnxp-10q_063022.htm   iXBRL 10-Q 888719
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-01.htm EX-31.01 10490
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-02.htm EX-31.02 10484
4 CERTIFICATION OF CHIEF EXECUTIVE AND FINANCIAL OFFICERS ex32-01.htm EX-32.01 5709
  Complete submission text file 0001387131-22-008503.txt   5044486

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE tnxp-20220630.xsd EX-101.SCH 55445
6 XBRL CALCULATION FILE tnxp-20220630_cal.xml EX-101.CAL 56503
7 XBRL DEFINITION FILE tnxp-20220630_def.xml EX-101.DEF 236398
8 XBRL LABEL FILE tnxp-20220630_lab.xml EX-101.LAB 372655
9 XBRL PRESENTATION FILE tnxp-20220630_pre.xml EX-101.PRE 314478
72 EXTRACTED XBRL INSTANCE DOCUMENT tnxp-10q_063022_htm.xml XML 624254
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36019 | Film No.: 221145305
SIC: 2834 Pharmaceutical Preparations